LIPOCINE INC. Financial and Nonfinancial Liabilities, Fair Value Disclosure
LIPOCINE INC. (LPCN) had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $33.99 million as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:LiabilitiesFairValueDisclosure · last filed 2022-11-09
- 2022-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $33.99M.
- 2022-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $37.76M.
- 2022-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $42.37M.
- 2021-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $46.57M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2022-09-30 | $33.99M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $37.76M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $42.37M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $46.57M 10-Q · filed 2022-11-09 |
| 2021-09-30 | $38.87M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $46.98M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $50.55M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $20.02M 10-K · filed 2022-03-09 |
| 2020-09-30 | $19.61M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $19.69M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $20.45M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $17.85M 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |